Abstract:Context: Diabetic nephropathy (DN) is a common microvascular complication in diabetic patients. The pathogenesis of DN is complex. Inflammatory response may play a key role as a common downstream pathway. Objective: The study intended to explore the relationship between the levels of plasma nucleotide-binding oligomeric domain-like receptor protein 3 (NLRP3 inflammasome), interleukin-1β (IL-1β), and IL-18 and the progression of type 2 diabetic nephropathy to clarify their relationship with type 2 diabetes mellitus (T2DM) and to provide evidence for clinical treatment. Design: The research team performed a controlled observational study. Setting: The study took place at Baoding No. 1 Central Hospital in Baoding, Hebei, China. Participants: Participants were 153 patients with T2DM who received treatment at the hospital between October 2020 and October 2021. The research team allocated 30 participants without evidence of DN to the control group. Based on the DN stage, the team assigned the 123 remaining participants to one of five observation groups: (1) 32 participants with stage 1 DN to the DN1 group, (2) 31 participants with stage 2 DN to the DN2 group, (3) 30 participants with stage 3 DN to the DN3 group, (4) 30 participants with stage 4 DN to the DN4 group, and (5) 29 participants with stage 5 DN to the DN5 group. Outcome measures: The research team measured participants' levels of "nucleotide binding oligomeric domain-like receptor protein 3" (NLRP3), interleukin-1 beta (IL-1β), and IL-18 and used the Spearman rank correlation analysis to determine the correlation between those levels and the DN stages. Results: The levels of NLRP3 , IL-1β and IL-18 in all the five observation groups were significantly higher than those in the control group (all P < .01). The levels were also significantly higher: (1) in the DN2, DN3, DN4, and DN5 groups than those in the DN1 group (all P < .01); (2) in the DN3, DN4, and DN5 groups than those in the DN2 group (all P < .01); (3) in the DN4 and DN5 groups than those in the DN3 group (all P < .01); and (4) in the DN5 groups than those in the DN4 group (all P < .01). The Spearman rank correlation analysis showed that the NLRP3, IL-1β, and IL-18 levels were significantly positively correlated with the DN stage (P = .01). Conclusions: NLRP3, IL-1β and IL-18 played an important role in the progression of T2DM, and their levels increased with the aggravation of DN. Therefore, the plasma levels of NLRP3, IL-1β and IL-18 can be useful as indicators of the occurrence and development of DN and can provide clinical guidance for the early diagnosis of DN and for the determination and adjustment of treatment plans.

Effect of NF-kB activity inhibition on function of dendritic cells in human peripheral blood and clinical efficacy of type Ⅰ diabetes

Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKCβ1-IRS1-NF-κB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes

The expression of NF-κB in peripheral blood mononuclear cells of type 2 diabetes patients and its related factors

Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription Factor-κB Activity

Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription Factor-Kappab Activity.

Modulatory Effects of CpG Oligonucleotide on Production of Th1 and Th2 Cytokines by Peripheral Blood Mononuclear Cells from Patients with Type 2 Diabetes Mellitus

The activation and significance of NF-kappaB in peripheral blood mononuclear cells isolated from subjects with various glucose toleranc

Effect of Intensive Insulin Therapy on Nuclear Factor-Κb Expression in Peripheral Blood Mononuclear Cell in Newly-Diagnosed Type 2 Diabetics

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab′)2 Antibody Treatment through Secreting Transforming Growth Factor-β

Changes of natural killer cells in peripheral blood in patients with newly-diagnosed type 1 diabetes mellitus

The Influence of Intensive Insulin Therapy on Nuclear Factor-Kappa B of PBMCs in Type 2 Diabetics with Oral Antidiabetic Drug Failure

Effects of Intensive Insulin Therapy on Monocyte Chemotactic Protein-1 and Nuclear Factor-Κb of Newly-Diagnosed Type 2 Diabetic Patients

High Frequency of Activated Natural Killer and Natural Killer T-cells in Patients with New Onset of Type 2 Diabetes Mellitus

[The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy]

Oral Nf-Kappa B Blockade Attenuates Pro-Inflammatory Cytokines in the Hypothalamic Paraventricular Nucleus of Streptozotocin-Induced Diabetes

Changes and Significance of NF-KB and MCP-1 Express on Peripheral Blood Mononuclear Cells in Patients with Diabetic Nephropathy

The Significant Changes of T Lymphocyte Subsets and Costimulatory Molecules in Type 1 Diabetes

Peripheral Blood Mononuclear Cells from Patients with Type 1 Diabetes and Diabetic Retinopathy Produce Higher Levels of IL-17A, IL-10 and IL-6 and Lower Levels of IFN-γ—A Pilot Study

The Relationship Between NR2E1 and Subclinical Inflammation in Newly Diagnosed Type 2 Diabetic Patients.

Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes

Decreased percentage of NKG2D+NK cells in patients with incident onset of Type 1 Diabetes.